FindTrial
Sign In

AMH combined INHB for the diagnosis of female central precocious puberty

AMH combined INHB for the diagnosis of female central precocious puberty

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038202
Enrollment
Unknown
Registered
2020-09-13
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central precocious puberty

Interventions

Gold Standard:GnRHa provoctive test
Index test:Anti&#32
Mullerian&#32
hormone,&#32
Inhibin&#32

Sponsors

Capital Institute of Pediatrics
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
5 Years to 8 Years

Inclusion criteria

Inclusion criteria: girls with premature breast development before 8 years.

Exclusion criteria

Exclusion criteria: Those who do not agree to participate in this study.

Design outcomes

Primary

MeasureTime frame
Anti Mullerian hormone;Inhibin B;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactLiu Ziqin

Capital Institute of Pediatrics

1934855597@qq.com+86 18501362924

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026